MapLight Therapeutics, Inc.
MPLT· Nasdaq
Released May 14, 2026, after the close
10-Q filed May 14, 2026, 44 days after period end · 0001193125-26-224129
| Metric | Q1 2026 | Q1 2025 | Q1 2024 |
|---|---|---|---|
| Net Income | -$60.67M | -$22.34M | -$18.94M |
| EPS Diluted | -$1.34 | -$29.33 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
MapLight Therapeutics, Inc. · CIK 1770069 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Mar 31, 2026 · filed May 14, 2026 · 44 d after period end
1.9% from the close of May 14, 2026 to the close of May 15, 2026, the first after the release.